Adverse Drug Reaction Classification System

         

Pharmaceutical Information
Drug Name Betaxolol
Drug ID BADD_D00263
Description A cardioselective beta-1-adrenergic antagonist with no partial agonist activity.
Indications and Usage For the management of hypertension.
Marketing Status approved; investigational
ATC Code C07AB05; S01ED02
DrugBank ID DB00195
KEGG ID D07526
MeSH ID D015784
PubChem ID 2369
TTD Drug ID D03ROX
NDC Product Code 42806-039; 24658-700; 42806-038; 24658-701
UNII O0ZR1R6RZ2
Synonyms Betaxolol | Betaxolol Hydrochloride | Hydrochloride, Betaxolol | Kerlone | Oxodal | Kerlon | SL-75212 | SL 75212 | SL75212 | ALO-1401-02 | ALO 1401 02 | ALO140102 | Betoptic | Betoptima | Betaxolol Alcon | Alcon, Betaxolol
Chemical Information
Molecular Formula C18H29NO3
CAS Registry Number 63659-18-7
SMILES CC(C)NCC(COC1=CC=C(C=C1)CCOCC2CC2)O
Chemical Structure
ADRs Induced by Drug
*The priority for ADR severity classification is based on FAERS assessment, followed by the most severe level in CTCAE rating. If neither is available, it will be displayed as 'Not available'.
**The 'Not Available' level is hidden by default and can be restored by clicking on the legend twice..
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Hypertrichosis23.02.04.002--
Hyperuricaemia14.09.01.003--
Hypoaesthesia17.02.06.023; 23.03.03.081--Not Available
Hypoaesthesia eye17.02.06.019; 06.01.01.007--Not Available
Hypoglycaemia14.06.03.001; 05.06.03.001--
Hypokalaemia14.05.03.002--
Hypotension24.06.03.002--
Immune system disorder10.02.01.001--Not Available
Increased appetite14.03.01.003; 08.01.09.027--Not Available
Infection11.01.08.002--Not Available
Influenza22.07.02.001; 11.05.03.001--Not Available
Insomnia19.02.01.002; 17.15.03.002--
Intermittent claudication24.04.03.001--Not Available
Iritis06.04.03.002; 10.02.01.022--Not Available
Keratitis06.04.02.002--
Lacrimation disorder06.08.02.010--Not Available
Lacrimation increased06.08.02.004--
Laryngospasm22.04.02.002--
Lethargy19.04.04.004; 08.01.01.008; 17.02.04.003--
Leukocytosis01.02.01.002--
Libido decreased21.03.02.005; 19.08.03.001--
Loss of consciousness17.02.04.004--Not Available
Lymphadenopathy01.09.01.002--Not Available
Malaise08.01.01.003--
Menstrual disorder21.01.01.004--Not Available
Mental disability26.01.01.001--Not Available
Mental impairment19.21.02.003; 17.03.03.002--Not Available
Mesenteric artery thrombosis24.01.08.003; 07.15.02.008--Not Available
Micturition disorder20.02.02.005--Not Available
Mood swings19.04.03.001--Not Available
The 4th Page    First    Pre   4 5 6 7 8    Next   Last    Total 8 Pages
ADReCS-Target
Drug Name ADR Term Target
Tip:  Drug Name  ADR Term  Protein  Variation  Gene